Aquestive Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Aquestive Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Aquestive Therapeutics Inc
Rating: 1.09741675
Author: Trendlyne DVM scores

about

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous Sys...

3.24 -0.01 (-0.31%)

57.09% Fall from 52W High

2.6M

XNAS Volume

XNAS 23 Jan, 2026 4:30 PM (EST)

Not Eligible

Expensive Valuation

7.7 / 100

Technically Neutral

36.2 / 100

1Yr Price target upside is 166%

8 analysts

Aquestive Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Aquestive Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous Sys...

57.09% Fall from 52W High

SWOT Analysis

Aquestive Therapeutics Inc Live Price Chart